A Non-Profit Approach to Address Foreign Dependence of Generic Drugs

Journal of Law, Medicine and Ethics 49 (1):30-33 (2021)
  Copy   BIBTEX

Abstract

The COVID-19 pandemic has revealed the vulnerability of the US generic drug supply chain to foreign production. Many policies have been proposed to mitigate this vulnerability. In this article, we argue that nonprofit drug manufacturers have the potential to make important contributions.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,323

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Drugs, Money, and Power: The Canadian Drug Shortage.Chris Kaposy - 2014 - Journal of Bioethical Inquiry 11 (1):85-89.
Grounding and ontological dependence.Henrik Rydéhn - 2021 - Synthese 198 (Suppl 6):1231-1256.

Analytics

Added to PP
2021-04-22

Downloads
10 (#1,199,114)

6 months
4 (#798,384)

Historical graph of downloads
How can I increase my downloads?

References found in this work

No references found.

Add more references